HOME >> MEDICINE >> NEWS
Belgium doctors treating critically ill infants favour legalising euthanasia

Most paediatricians in Flanders, Belgium, favour the legalisation of lethal drugs to end the life of some critically ill babies and infants, concludes a study in this week's issue of THE LANCET.

Doctors are increasingly confronted with end-of-life decisions in critically ill babies and infants. Little is known about the frequency of end-of-life decisions in this population, the clinical and demographic characteristics of these patients, and the attitudes of doctors who care for these patients.

Luc Deliens (Vrije Universiteit Brussel, Belgium) and colleagues looked at the death certificates for all neonates and infants in the whole of Flanders who died between August 1999 and July 2000. 292 children were born alive and died in Flanders within the first year of life over this period. 175 doctors in charge of these cases were identified and sent anonymous questionnaires. 121 of the 175 doctors involved completed the attitude questions.

An end-of-life decision was made in 143 cases (57%). End-of-life decisions include withdrawing or withholding treatment, using drugs to alleviate pain that could potentially shorten life, or using drugs with the explicit intention of shortening the patient's life. The use of lethal drugs in minors is illegal in Belgium. However, the study found that lethal doses or lethal drugs were administered in 17 cases (9%). 95 (79%) of the 121 doctors thought that their professional duty sometimes includes the prevention of unnecessary suffering by hastening death and 69 (58%) of 120 supported legalisation of termination in some cases.

Professor Deliens states: "We found that about three in four physicians who are confronted with critically ill neonates and infants are willing to participate in certain forms of life termination in these children. The main reasons for shortening of the neonate's life were the absence of real survival chances, and, if the baby survived, an expected very poor quality of life." '"/>

Contact: Udani Samarasekera
pressoffice@lancet.com
44-207-424-4949
Lancet
7-Apr-2005


Page: 1 2

Related medicine news :

1. 6 out of 10 doctors arent frustrated that patients cant lower cholesterol
2. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
3. New doctors test kit to help prevent debilitating osteoporosis
4. Italian doctors get their information on medicines from drug company sales reps
5. Approved medical resident hours still resulting in sleepy doctors
6. MTAS will cause irreparable harm to 10,000 junior doctors
7. Africas doctors access assessed
8. Did drug reps encourage doctors to prescribe gabapentin for nonapproved uses?
9. Drug company sales visits influenced doctors, study finds
10. Drug reps use friendship to influence doctors
11. US Senate introduces bill to train more preventive medicine doctors

Post Your Comments:
(Date:5/21/2013)... OK (PRWEB) May 21, 2013 Representatives with ... been such a success that the company has achieved its ... plan from day one was to move Hammerhead Bicycles from ... Spokesman and President Scott Robertson. , Robertson explained that the ... and continue to exclusively focus on all things 29er and ...
(Date:5/21/2013)... TheBeautyPlace.com helps brides to breathe a ... Big Day Kit including all the essentials a glowing ... on their Wedding Day. , TheBeautyPlace.com features Wedding Day ... their Wedding Day. Flowers blooming and warmer weather indicates ... season. From Memorial Day to October, brides to be ...
(Date:5/21/2013)... May 2013 EMBO announced today that 52 outstanding ... its membership. Forty-three of the researchers reside in Europe ... of nine Associate Members from Canada, China, India, Japan ... around 1600 life scientists. , "Our members are the ... Director Maria Leptin said. "We have been building our ...
(Date:5/21/2013)... May 21, 2013 Healthcare industry leaders, ... the premier “Start Me Up” Emerging Healthcare Technology Conference, ... in Madison, Wisconsin. This new event is part ... gathering of national healthcare leaders being held June 10-12 ... University of Wisconsin. , Funding for healthcare information technology ...
(Date:5/21/2013)... A plastic surgery Internet marketing ... surgery SEO services following an Internet survey. , ... the “Best Plastic Surgery SEO Services”. , Sources ... predictable. Well-known in the plastic surgery Internet marketing ... any other selection based on superior client results. ...
Breaking Medicine News(10 mins):Health News:Hammerhead Bicycles Now a Standalone Brand 2Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 2Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 3Health News:EMBO announces 52 new members for 2013 2Health News:“Start Me Up" Healthcare Conference: Where Healthcare CIOs, Entrepreneurs and Investors Meet 2Health News:JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO 2
(Date:5/21/2013)... , May 21, 2013  Lehigh Valley Health Network ... TM devices, adding to its existing arsenal of ... taking up residence within the network, LVHN is now ... to proactively combat superbugs and provide the best possible ... Room Ultraviolet Disinfector, TRU-D – the signature product of ...
(Date:5/21/2013)... SUNNYVALE, Calif. , May 21, 2013 /PRNewswire/ ... ), announced today the publication of study results ... the CyberKnife® Robotic Radiosurgery System, the most widely ... (SBRT). The study followed 304 patients for a ... years post-treatment and found that 97 percent of ...
(Date:5/21/2013)... 21, 2013  Janssen R&D Ireland (Janssen) today ... global Phase 3 PROMISE study demonstrating that use ... to sustained virologic response 12 weeks after the ... treatment-experienced genotype 1 chronic hepatitis C adult patients ... liver fibrosis, when administered once daily with pegylated ...
Breaking Medicine Technology:Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7
Cached News: